Vistagen Therapeutics, Inc. (VTGN)
0.2388
0.00 (0.00%)
USD |
NASDAQ |
Sep 10, 14:58
Vistagen Therapeutics Price to Book Value : 0.4329 for Sept. 10, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 09, 2026 | 0.4269 |
| September 08, 2026 | 0.4413 |
| September 04, 2026 | 0.4402 |
| September 03, 2026 | 0.4463 |
| September 02, 2026 | 0.446 |
| September 01, 2026 | 0.4411 |
| August 31, 2026 | 0.4623 |
| August 28, 2026 | 0.4585 |
| August 27, 2026 | 0.4659 |
| August 26, 2026 | 0.4714 |
| August 25, 2026 | 0.4503 |
| August 24, 2026 | 0.442 |
| August 21, 2026 | 0.4423 |
| August 20, 2026 | 0.4371 |
| August 19, 2026 | 0.4425 |
| August 18, 2026 | 0.4387 |
| August 17, 2026 | 0.4714 |
| August 14, 2026 | 0.4851 |
| August 13, 2026 | 0.4828 |
| August 12, 2026 | 0.4735 |
| August 11, 2026 | 0.4879 |
| August 10, 2026 | 0.4782 |
| August 07, 2026 | 0.5214 |
| August 06, 2026 | 0.5145 |
| August 05, 2026 | 0.5384 |
| Date | Value |
|---|---|
| August 04, 2026 | 0.5439 |
| August 03, 2026 | 0.4442 |
| July 31, 2026 | 0.4369 |
| July 30, 2026 | 0.4369 |
| July 29, 2026 | 0.4411 |
| July 28, 2026 | 0.422 |
| July 27, 2026 | 0.4173 |
| July 24, 2026 | 0.4104 |
| July 23, 2026 | 0.4097 |
| July 22, 2026 | 0.424 |
| July 21, 2026 | 0.426 |
| July 20, 2026 | 0.419 |
| July 17, 2026 | 0.4155 |
| July 16, 2026 | 0.4351 |
| July 15, 2026 | 0.4512 |
| July 14, 2026 | 0.4462 |
| July 13, 2026 | 0.4581 |
| July 10, 2026 | 0.4677 |
| July 09, 2026 | 0.4518 |
| July 08, 2026 | 0.4257 |
| July 07, 2026 | 0.4295 |
| July 06, 2026 | 0.4456 |
| July 02, 2026 | 0.4512 |
| July 01, 2026 | 0.4405 |
| June 30, 2026 | 0.4097 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.637 |
| Alnylam Pharmaceuticals, Inc. | 24.53 |
| Anika Therapeutics, Inc. | 2.029 |
| Savara, Inc. | 7.542 |
| Vericel Corp. | 5.233 |
Price to Book Value Related Metrics
| PS Ratio | 3.832 |
| Price | 0.2388 |
| Earnings Yield | -713.9% |
| Market Cap | 10.60M |